|
|
Volumn 94, Issue 17, 2002, Pages 1270-1272
|
|
Despite checkered past, thalidomide and its analogues show potential
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
DEXAMETHASONE;
IMMUNOMODULATING AGENT;
LENALIDOMIDE;
THALIDOMIDE;
THALIDOMIDE DERIVATIVE;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
CONSTIPATION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SAFETY;
DRUG WITHDRAWAL;
HUMAN;
KIDNEY CARCINOMA;
MULTIPLE MYELOMA;
NEUROTOXICITY;
NONHUMAN;
NOTE;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
SEDATION;
SKIN DISEASE;
TERATOGENICITY;
|
|
EID: 0037019732
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.17.1270 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|